These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34369356)
1. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Kitamura N; Sugiyama K; Nagasawa Y; Hamaguchi M; Kobayashi H; Takei M Clin Exp Rheumatol; 2022 Jul; 40(7):1330-1335. PubMed ID: 34369356 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature. Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis. Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis. Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828 [TBL] [Abstract][Full Text] [Related]
6. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report. Omameuda T; Miyato H; Sata N; Lefor AK Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761 [TBL] [Abstract][Full Text] [Related]
9. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264 [TBL] [Abstract][Full Text] [Related]
11. Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD. Kondo M; Murakawa Y; Moriyama M; Honda M; Sugiura T; Onoda K; Watanabe Y; Kakimaru H Mod Rheumatol; 2021 Jan; 31(1):88-93. PubMed ID: 32075469 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature. He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis. Kaito S; Goto M; Iguchi M; Okuno Y; Moriyoshi K; Koyama H Mod Rheumatol Case Rep; 2021 Jan; 5(1):141-144. PubMed ID: 33269654 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors. Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250 [TBL] [Abstract][Full Text] [Related]
16. Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Kondo S; Tanimoto K; Yamada K; Yoshimoto G; Suematsu E; Fujisaki T; Oshiro Y; Tamura K; Takeshita M; Okamura S Virchows Arch; 2013 Apr; 462(4):399-407. PubMed ID: 23494713 [TBL] [Abstract][Full Text] [Related]
17. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report. Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Gion Y; Iwaki N; Takata K; Takeuchi M; Nishida K; Orita Y; Tachibana T; Yoshino T; Sato Y Cancer Sci; 2017 Jun; 108(6):1271-1280. PubMed ID: 28380678 [TBL] [Abstract][Full Text] [Related]